Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics granted stock options for 20,807 shares and 13,793 RSUs to eight new employees. The awards were issued as material inducements to employment under Nasdaq Listing Rule 5635(c)(4), with options priced at $75.85 per share.
Key figures
- Rsus granted
- 13793
- Options granted
- 20807
- Employees granted
- 8
- Option exercise price
- 75.85
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.